image

The best stocks to buy since 1993

Our latest issue will be released in 12 days, don't miss out!

SIGN UP NOW
Secondary Recommendation

Derriston - Cash shell chaired by Harry Hyman of PHP targets medical devices space

March 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DERR
  • Price:
  • 15.75p
Derriston (DERR;15.75p), a cash shell, crept onto the Full List in December and intends to move into the medical products and devices sector. The business is the brainchild of Harry Hyman (chairman) and Rodger Sargent (CEO). Hyman won his spurs at Primary Health Properties, a very well run business that has exploited the demand from the NHS to rent health care property (such as purpose built doctors surgeries). Sargent is a shell miester who has done his bit in reversals including Satellite, Audioboom and Sports Internet. Both are incentivised with founder shares. Derriston’s register includes Nigel Wray (8%), Stephen Hemsley (8%) and Hargreaves Hale (10%).   ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW